The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ANAPTYSBIO INC | COM | 032724106 | 7,784,270 | 357,733 | SH | SOLE | 357,733 | 0 | 0 | |||
| ARVINAS INC | COM | 04335A105 | 8,742,400 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | |||
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 10,216,269 | 665,555 | SH | SOLE | 665,555 | 0 | 0 | |||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 1,440,829 | 1,134,511 | SH | SOLE | 1,134,511 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 8,528,848 | 790,440 | SH | SOLE | 790,440 | 0 | 0 | |||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 13,848,313 | 862,286 | SH | SOLE | 862,286 | 0 | 0 | |||
| DISC MEDICINE INC | COM | 254604101 | 12,469,086 | 588,442 | SH | SOLE | 588,442 | 0 | 0 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 126,986,603 | 5,798,475 | SH | SOLE | 5,798,475 | 0 | 0 | |||
| ENTRADA THERAPEUTICS INC | COM | 29384C108 | 63,921,496 | 4,408,379 | SH | SOLE | 4,408,379 | 0 | 0 | |||
| FIBROGEN INC | COM | 31572Q808 | 10,812,238 | 579,434 | SH | SOLE | 579,434 | 0 | 0 | |||
| HOMOLOGY MEDICINES INC | COM | 438083107 | 4,671,997 | 4,535,919 | SH | SOLE | 4,535,919 | 0 | 0 | |||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 11,924,780 | 868,520 | SH | SOLE | 868,520 | 0 | 0 | |||
| IMPEL PHARMACEUTICALS INC | COM | 45258K109 | 4,038,707 | 2,884,791 | SH | SOLE | 2,884,791 | 0 | 0 | |||
| IVERIC BIO INC | COM | 46583P102 | 6,924,951 | 284,626 | SH | SOLE | 284,626 | 0 | 0 | |||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 4,870,350 | 1,185,000 | SH | SOLE | 1,185,000 | 0 | 0 | |||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 831,130 | 38,856 | SH | SOLE | 38,856 | 0 | 0 | |||
| PEAR THERAPEUTICS INC | CLASS A COM | 704723105 | 4,269,749 | 16,744,113 | SH | SOLE | 16,744,113 | 0 | 0 | |||
| PHARVARIS N V | COM | N69605108 | 4,733,118 | 587,600 | SH | SOLE | 587,600 | 0 | 0 | |||
| RALLYBIO CORP | COM | 75120L100 | 20,731,434 | 3,630,724 | SH | SOLE | 3,630,724 | 0 | 0 | |||
| SCPHARMACEUTICALS INC | COM | 810648105 | 10,889,868 | 1,200,647 | SH | SOLE | 1,200,647 | 0 | 0 | |||
| SPRUCE BIOSCIENCES INC | COM | 85209E109 | 5,224,440 | 2,364,000 | SH | SOLE | 2,364,000 | 0 | 0 | |||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 5,827,500 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 7,123,200 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | |||
| VOR BIOPHARMA INC | COM | 929033108 | 34,226,070 | 6,361,723 | SH | SOLE | 6,361,723 | 0 | 0 | |||